Cat. No.: HY-16589

Oligomycin A

(Synonyms: MCH 32)

52 Cited Publications

Customer Review

Based on 52 publication(s) in Google Scholar

Oligomycin A (MCH 32), created by Streptomyces, acts as a mitochondrial F₀F₁-ATPase inhibitor, with a K_i of 1 μM; Oligomycin A shows anti-fungal activity.

For research use only. We do not sell to patients.

Purity: 99.91%
CAS No.: 579-13-5
Formula: C₄₅H₇₄O₁₁
Molecular Weight:791.06

Storage:

Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month

Oligomycin A Chemical Structure

CAS No.: 579-13-5

Size

Price

Stock

Quantity

Sample (0.1mg)

In-stock

(In Japan)

Apply Now

Get Quote Ask For Quote & Lead Time Consult sales personnel for more information Check price and availability Get Quote Ask For Quote & Lead Time Consult sales personnel for more information Check price and availability

Bulk Inquiry

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- IC₅₀ & Target
- Cellular Effect
- In Vitro
Chemical Information
Publications (52)
Solvent & Solubility
- In Vitro
- In Vivo
Protocol
Purity & Documentation
References
Help & FAQs
Bioz

Biological Activity

Description

Oligomycin A (MCH 32), created by Streptomyces, acts as a mitochondrial F₀F₁-ATPase inhibitor, with a K_i of 1 μM; Oligomycin A shows anti-fungal activity.

IC₅₀ & Target

Ki: 1 μM (F₀F₁-ATPase)^[1]

All Antibiotic Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
HCT-116	IC₅₀	0.9 μM Compound: Oligomycin A	Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 32942072]
HCT-116	IC₅₀	1 μM Compound: Oligomycin A	Antitumor activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Antitumor activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 32942072]
K562	IC₅₀	0.2 μM Compound: Oligomycin A	Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 32942072]
K562	IC₅₀	0.2 μM Compound: Oligomycin A	Antitumor activity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Antitumor activity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 32942072]
SH-SY5Y	IC₅₀	29 μM Compound: Oligomycin A	Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability after 24 hrs by MTT assay Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability after 24 hrs by MTT assay	[PMID: 27689727]

In Vitro

Oligomycin A is a mitochondrial F₀F₁-ATPase inhibitor with a K_i of 1 μM. Oligomycin A shows cytotoxic to the NCI-60 cell lines, with GI₅₀ of 10 nM. Oligomycin A also inhibits the activity of Triton X-100-solubilized ATPase with a K_i of 0.1 μM. Furthermore, Oligomycin A has anti-fungal activity^[1]. Oligomycin A (2.4 μM) inhibits the ability of spermatozoa to achieve feasible in vitro capacitation (IVC), and also suppresses progesterone-induced in vitro acrosome exocytosis (IVAE) as well as the concomitant peaks of O₂ consumption and ATP levels^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS No. 579-13-5
Appearance Solid
Molecular Weight 791.06
Formula C₄₅H₇₄O₁₁
Color White to off-white
SMILES

O=C(/C=C/[C@H](C)[C@@H](O)[C@H](C)C([C@H](C)[C@@H](O)[C@@H]1C)=O)O[C@@]([C@@H]2C)([H])[C@H](C)[C@@]3(CC[C@H](C)[C@H](C[C@H](O)C)O3)O[C@@]2([H])CC[C@@H](CC)/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C1=O
Synonyms

MCH 32
Structure Classification
- Antibiotics
- Macrolide Antibiotics
Initial Source
- Microorganisms
Streptomyces diastatochromogenes
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

Publications (52)

All Bio/Physico-chemical AssayCell Imaging/Staining

Sort by:

Journal Impact Factor

Signal Transduct Target Ther

Disruption of heme homeostasis by nuclear receptor Nur77 induces pyroptosis through granzyme B-dependent GSDMC cleavage. [Abstract]

2025 Dec 17;10(1):413. PMID: 41407678
Nature

Proteasome-guided haem signalling axis contributes to T cell exhaustion. [Abstract]

2026 May;653(8114):548-557. PMID: 41851457
Cell Metab

Ultrasensitive sensors reveal the spatiotemporal landscape of lactate metabolism in physiology and disease. [Abstract]

2023 Jan 3;35(1):200-211.e9. PMID: 36309010

Oligomycin A purchased from MedChemExpress. Usage Cited in: Cell Metab. 2023 Jan 3;35(1):200-211.e9. [Abstract]

Inhibition of oxidative phosphorylation using the complex I inhibitor rotenone or the complex V inhibitor oligomycin A (3.5 μM) resulted in increased extracellular and subcellular lactate levels due to compensatory upregulation of glycolysis.
Cell Res

The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8. [Abstract]

2021 Sep;31(9):980-997. PMID: 34012073
Nat Metab

NK cell-derived IFNγ mobilizes free fatty acids from adipose tissue to promote early B cell activation during viral infection. [Abstract]

2025 Apr 11. PMID: 40217117
Cell Stem Cell

Highly efficient and rapid generation of human pluripotent stem cells by chemical reprogramming. [Abstract]

2023 Apr 6;30(4):450-459.e9. PMID: 36944335
Nat Aging

Mitochondria-enriched hematopoietic stem cells exhibit elevated self-renewal capabilities, thriving within the context of aged bone marrow. [Abstract]

2025 May;5(5):831-847. PMID: 40050412
Mol Cell

Structure of the human ATP synthase. [Abstract]

2023 Jun 15;83(12):2137-2147.e4. PMID: 37244256
Nat Protoc

Comprehensive multiscale analysis of lactate metabolic dynamics in vitro and in vivo using highly responsive biosensors. [Abstract]

2024 May;19(5):1311-1347. PMID: 38307980

Oligomycin A purchased from MedChemExpress. Usage Cited in: Nat Protoc. 2024 May;19(5):1311-1347. [Abstract]

Quantitative analysis of FiLa expression in cytosol (Oligo, 1 μM).

Oligomycin A purchased from MedChemExpress. Usage Cited in: Nat Protoc. 2024 May;19(5):1311-1347. [Abstract]

Fluorescent images of FiLa expressed in cytosol (Oligo, 1 μM).

Oligomycin A purchased from MedChemExpress. Usage Cited in: Nat Protoc. 2024 May;19(5):1311-1347. [Abstract]

After sequentially injecting Glucose (Glc, 1 mM), Oligomycin (Oligo, 1 μM, 20 min), and 2-deoxyglucose (2-DG, 50 mM) into HEK-293 cells (n = 9), extracellular acidification rate (ECAR) was measured using a Seahorse XF96 analyzer to perform glycolytic stress testing.
Nat Commun

Remission spectroscopy resolves the mechanism of action of bedaquiline within living mycobacteria. [Abstract]

2025 Nov 25;16(1):11018. PMID: 41290674

Oligomycin A purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Nov 25;16(1):11018. [Abstract]

OCR traces of HEK293T cells treated with 10 µM bedaquiline (BDQ), ethanol vehicle control (EtOH), and 1.5 µM Oligomycin A for 5 min. Arrow indicates the time point at which drug was added.
Nat Commun

DELE1 tracks perturbed protein import and processing in human mitochondria. [Abstract]

2022 Apr 6;13(1):1853. PMID: 35388015
Bone Res

Osteoclasts control endochondral ossification via regulating acetyl-CoA availability. [Abstract]

2024 Aug 28;12(1):49. PMID: 39198395
Adv Sci (Weinh)

Single-Mitochondrion ATP Profiling Directs Discovery of Targetable OXPHOS Dependency in Cancers. [Abstract]

2026 Apr;13(21):e13341. PMID: 41684301
Redox Biol

Activation of sclerostin inhibits Isg20-Mediated aerobic glycolysis ameliorating renal Fibrosis: the renoprotective mechanism of hederagenin in CKD. [Abstract]

2025 Sep:85:103762. PMID: 40644925
Redox Biol

Enteric coronavirus PDCoV evokes a non-Warburg effect by hijacking pyruvic acid as a metabolic hub. [Abstract]

2024 May:71:103112. PMID: 38461791
Nano Today

1 June 2022.
Cell Rep Med

Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia. [Abstract]

2024 May 16:101580. PMID: 38776913
Proc Natl Acad Sci U S A

METTL3 mediates atheroprone flow-induced glycolysis in endothelial cells. [Abstract]

2025 May 13;122(19):e2424796122. PMID: 40327688
Dev Cell

SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis. [Abstract]

2024 May 17:S1534-5807(24)00296-X. PMID: 38776924
BMC Med

Enhancing anti-CD3 mAb-mediated diabetes remission in autoimmune diabetes through regulation of dynamin-related protein 1(Drp1)-mediated mitochondrial dynamics in exhausted CD8+T-cell subpopulations. [Abstract]

2025 Mar 31;23(1):189. PMID: 40165248
ACS Appl Mater Interfaces

Peptide Hydrogels for Renal Carcinoma Therapy via Synergistic Inhibition of Glycolysis and Mitochondrial Metabolism Reprogramming. [Abstract]

2025 Jun 25;17(25):36487-36496. PMID: 40518708
NPJ Precis Oncol

Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancers. [Abstract]

2026 Apr 16. PMID: 41991605
Cell Mol Gastroenterol Hepatol

Gut microbiota-derived glutamine attenuates liver ischemia/reperfusion injury via macrophage metabolic reprogramming. [Abstract]

2023;15(5):1255-1275. PMID: 36706918
PLoS Biol

HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma. [Abstract]

2021 Apr 27;19(4):e3001197. PMID: 33905408
Cell Rep

A generalized strategy to kill leukemic cells by targeting the regulatory systems governing mitochondrial membrane potential. [Abstract]

2025 Nov 25;44(11):116496. PMID: 41166305
Cell Rep

Blocking glycogen synthase 1 in white adipose tissue alleviates hypermetabolism following severe burn injury through inhibition of JAK2 by UDPG. [Abstract]

2025 Nov 18;44(12):116577. PMID: 41259203
Cell Rep

PI5P4Kα promotes glucose and iron acquisition to support metabolic fitness in pancreatic cancer. [Abstract]

2025 Aug 29;44(9):116199. PMID: 40884794
Cell Rep

DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation. [Abstract]

2021 Sep 21;36(12):109739. PMID: 34551297
Clin Transl Med

FABP4 deactivates NF-κB-IL1α pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression. [Abstract]

2021 Apr;11(4):e395. PMID: 33931964
Elife

Metformin abrogates pathological TNF-α-producing B cells through mTOR-dependent metabolic reprogramming in polycystic ovary syndrome. [Abstract]

2022 Jun 24;11:e74713. PMID: 35748536
Drug Des Devel Ther

Dexmedetomidine Ameliorates Cardiac Ischemia/Reperfusion Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT3 Pathway. [Abstract]

2023 Oct 25:17:3205-3218. PMID: 37908314
Int J Mol Sci

Modulating p-AMPK/mTOR Pathway of Mitochondrial Dysfunction Caused by MTERF1 Abnormal Expression in Colorectal Cancer Cells. [Abstract]

2022 Oct 15;23(20):12354. PMID: 36293209
Cancer Sci

Noncanonical TCA cycle fosters canonical TCA cycle and mitochondrial integrity in acute myeloid leukemia. [Abstract]

2025 Jan;116(1):152-163. PMID: 39479926
Poult Sci

Exploring ANT1 dysfunction as a pathological driver of wooden breast myopathy in broiler chickens. [Abstract]

2025 Aug 26;104(11):105730. PMID: 40972420
iScience

Tracking fructose 1,6-bisphosphate dynamics in liver cancer cells using a fluorescent biosensor. [Abstract]

2024 Nov 6;27(12):111336. PMID: 39640569
iScience

Prenatal hormone stress triggers embryonic cardiac hypertrophy outcome by ubiquitin-dependent degradation of mitochondrial mitofusin 2. [Abstract]

2023 Dec 8;27(1):108690. PMID: 38235340
Sci Rep

Intracellular pH links energy metabolism to lymphocyte death and proliferation. [Abstract]

2025 Sep 25;15(1):32878. PMID: 40998896
Sci Rep

Differentiation of cancer stem cells into erythroblasts in the presence of CoCl2. [Abstract]

2021 Dec 14;11(1):23977. PMID: 34907219
Heliyon

eIF2α-mediated integrated stress response links multiple intracellular signaling pathways to reprogram vascular smooth muscle cell fate in carotid artery plaque. [Abstract]

2024 Feb 23;10(5):e26904. PMID: 38434290
Stem Cells

Basic fibroblast growth factor promotes mesenchymal stem cell migration by regulating glycolysis-dependent β-catenin signaling. [Abstract]

2023 Jun 15;41(6):628-642. PMID: 36951300
Cell Cycle

SIRT3 suppression resulting from the enhanced β-catenin signaling drives glycolysis and promotes hypoxia-induced cell growth in hepatocellular carcinoma cells. [Abstract]

2024 Feb;23(4):435-447. PMID: 38626328
J Leukoc Biol

Bone marrow microenvironment drives AML cell OXPHOS addiction and AMPK inhibition to resist chemotherapy. [Abstract]

2022 Aug;112(2):299-311. PMID: 34927743
Vet Microbiol

Porcine reproductive and respiratory syndrome virus infection manipulates central carbon metabolism. [Abstract]

2023 Apr:279:109674. PMID: 36739813
Prostate

MEIS2 Modulates Oxidative Phosphorylation and ROS Generation to Affect CD8+ T Cell Antitumor Immunity in Prostate Cancer. [Abstract]

2025 Oct 1. PMID: 41031828
Nutr Cancer

Metabolic Alterations Induced by Kudingcha Lead to Cancer Cell Apoptosis and Metastasis Inhibition. [Abstract]

2020;72(4):696-707. PMID: 31352802
Cell Physiol Biochem

Metabolic Shift Induced by ω -3 PUFAs and Rapamycin Lead to Cancer Cell Death. [Abstract]

2018;48(6):2318-2336. PMID: 30114709
STAR Protoc

Protocol for real-time glycolytic monitoring in mammalian cells using confocal microscopy and HYlight, a biosensor for fructose 1,6-bisphosphate. [Abstract]

2025 Apr 23;6(2):103792. PMID: 40279243
STAR Protoc

Protocol for real-time assessment of mitochondrial and glycolytic ATP production in patient-derived glioma stem-like cells. [Abstract]

2024 Jun 27;5(3):103159. PMID: 38941182
University of Rijeka

2025.
Research Square Print

September 9th, 2022.
Oxid Med Cell Longev

Ketone Body β-Hydroxybutyrate Prevents Myocardial Oxidative Stress in Septic Cardiomyopathy. [Abstract]

2022 Mar 18;2022:2513837. PMID: 35340211
SSRN

15 Sep 2021 .

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (126.41 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Ethanol : 100 mg/mL (126.41 mM; ultrasonic and heat to 60°C)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

1.2641 mL

6.3206 mL

12.6413 mL

5 mM

0.2528 mL

1.2641 mL

2.5283 mL

10 mM

0.1264 mL

0.6321 mL

1.2641 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (3.16 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: 2.5 mg/mL (3.16 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: ≥ 2.5 mg/mL (3.16 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

Protocol 4

Add each solvent one by one: 10% EtOH 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (3.16 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 5

Add each solvent one by one: 10% EtOH 90% Corn Oil

Solubility: ≥ 2.5 mg/mL (3.16 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Protocol

Cell Assay^[1]

Drug (Oligomycin A, etc.) dilutions are added to monolayer or suspension cells in 96 well plates in triplicate for varying times. MTT is then added to the wells at a final concentration of 0.5 mg/mL. Supernatant is removed after pelleting the reduced MTT crystals. The crystals are fully dissolved in 40 mM HCl in isopropanol. Plates are scanned on a microplate reader at 595 nm^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (279 KB)
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Portuguese - PT (396 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Salomon AR, et al. Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase. Chem Biol. 2001 Jan;8(1):71-80. [Content Brief]

[2]. Ramió-Lluch L, et al. Oligomycin A-induced inhibition of mitochondrial ATP-synthase activity suppresses boar sperm motility and in vitro capacitation achievement without modifying overall sperm energy levels. Reprod Fertil Dev. 2014;26(6):883-97. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO / Ethanol	1 mM	1.2641 mL	6.3206 mL	12.6413 mL	31.6032 mL
	5 mM	0.2528 mL	1.2641 mL	2.5283 mL	6.3206 mL
	10 mM	0.1264 mL	0.6321 mL	1.2641 mL	3.1603 mL
	15 mM	0.0843 mL	0.4214 mL	0.8428 mL	2.1069 mL
	20 mM	0.0632 mL	0.3160 mL	0.6321 mL	1.5802 mL
	25 mM	0.0506 mL	0.2528 mL	0.5057 mL	1.2641 mL
	30 mM	0.0421 mL	0.2107 mL	0.4214 mL	1.0534 mL
	40 mM	0.0316 mL	0.1580 mL	0.3160 mL	0.7901 mL
	50 mM	0.0253 mL	0.1264 mL	0.2528 mL	0.6321 mL
	60 mM	0.0211 mL	0.1053 mL	0.2107 mL	0.5267 mL
	80 mM	0.0158 mL	0.0790 mL	0.1580 mL	0.3950 mL
	100 mM	0.0126 mL	0.0632 mL	0.1264 mL	0.3160 mL

Keywords

Oligomycin A

52 Cited Publications

100 mg Get Quote

Subscribe to the

MedChemExpress

Newsletter

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

Oligomycin A

Anti-Infection Compound Library

Membrane Transporter/Ion Channel Compound Library

Natural Product Library

Anti-Cancer Compound Library

Macrocyclic Compound Library

Antifungal Compound Library

Antibiotics Library

Microbial Metabolite Library

Mitochondria-Targeted Compound Library

Glucose Metabolism Compound Library

Targeted Diversity Library

Anti-Cancer Natural Product Library

Heterocyclic Compound Library

Mitochondrial Toxicity Compound Library

Multi-Target Compound Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Natural Product Library Plus

Natural Product and Natural Product-Like Compound Library

Bioactive Compound Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Natural Product Diversity Scaffold Library

Bacteria-Sourced Compound Library

Mass Spectrometry Natural Product Library

Publications Citing Use of MedChemExpress (MCE) Oligomycin A

All Antibiotic Isoforms

Biological Activity

Chemical Information

Publications (52)

Solvent & Solubility

Protocol

Purity & Documentation

References

Help & FAQs

Complete Stock Solution Preparation Table

Oligomycin A

Anti-Infection Compound Library

Membrane Transporter/Ion Channel Compound Library

Natural Product Library

Anti-Cancer Compound Library

Macrocyclic Compound Library

Antifungal Compound Library

Antibiotics Library

Microbial Metabolite Library

Mitochondria-Targeted Compound Library

Glucose Metabolism Compound Library

Targeted Diversity Library

Anti-Cancer Natural Product Library

Heterocyclic Compound Library

Mitochondrial Toxicity Compound Library

Multi-Target Compound Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Natural Product Library Plus

Natural Product and Natural Product-Like Compound Library

Bioactive Compound Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Natural Product Diversity Scaffold Library

Bacteria-Sourced Compound Library

Mass Spectrometry Natural Product Library

Publications Citing Use of MedChemExpress (MCE) Oligomycin A

All Antibiotic Isoforms

Biological Activity

Chemical Information

Publications (52)

Solvent & Solubility

Protocol

Purity & Documentation

References

Help & FAQs

Complete Stock Solution Preparation Table

Oligomycin A Related Classifications

Cat. No.: HY-16589